Orphan drug re-assessments
What happens when the sales for an orphan drug exceed €50 mn in a 12 months period?
Tag: G-BA
G-BA publishes an overview of all method assessments
For anyone working on German market access and / or medical devices, these G-BA news might be interesting. The link to the